Toronto Dominion Bank
ORKA

Toronto Dominion Bank’s Oruka Therapeutics ORKA Stock Holding History

Toronto Dominion Bank’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.55M Buy
+89,837
New +$5.99M 0.01% 743
2025
Q4 		– Sell
-58,332
Closed -$1.12M – 2316
2025
Q3 		$1.12M Hold
58,332
– – ﹤0.01% 1160
2025
Q2 		$654K Hold
58,332
– – ﹤0.01% 1152
2025
Q1 		$598K Hold
58,332
– – ﹤0.01% 1135
2024
Q4 		$1.13M Buy
+58,332
New +$1.42M ﹤0.01% 1031

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Toronto Dominion Bank's ORKA Position: Q2 2026 in Review

Toronto Dominion Bank opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 89,837 shares worth $8.55M. The stake represents 0.01% of the portfolio and ranks #743 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in ORKA as recently as Q3 2025.

Toronto Dominion Bank first reported a position in ORKA in Q4 2024 and has held it in 5 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Toronto Dominion Bank held 89,837 shares of Oruka Therapeutics worth $8.55M as of Q2 2026.
  • Oruka Therapeutics was a new Toronto Dominion Bank position in Q2 2026.
  • Oruka Therapeutics made up 0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #743 holding.
  • Toronto Dominion Bank first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.